Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Urgency, utility, and time horizon of transplant benefit.

Vitale A, Volk M, Cillo U.

Liver Transpl. 2015 Apr;21(4):565-6. doi: 10.1002/lt.24082. Epub 2015 Mar 12. No abstract available.

2.

Liver transplantation for hepatocellular carcinoma through the lens of transplant benefit.

Cillo U, Vitale A, Polacco M, Fasolo E.

Hepatology. 2017 May;65(5):1741-1748. doi: 10.1002/hep.28998. Epub 2017 Mar 16. Review. No abstract available.

PMID:
28010048
3.

"Survival benefit": the final destination, with still a long way to go.

Piscaglia F, Cucchetti A, Bolondi L.

Dig Liver Dis. 2010 Sep;42(9):608-10. doi: 10.1016/j.dld.2010.07.001. No abstract available.

PMID:
20678743
4.

Response.

Wald C, Russo MW, Heimbach JK, Hussain HK, Pomfret EA, Bruix J.

Radiology. 2013 Nov;269(2):619-20. No abstract available.

PMID:
24312935
5.

New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma.

Wald C, Russo MW, Heimbach JK, Hussain HK, Pomfret EA, Bruix J.

Radiology. 2013 Feb;266(2):376-82. doi: 10.1148/radiol.12121698. No abstract available.

PMID:
23362092
6.

Liver organ allocation for hepatocellular carcinoma: are we sure?

Marsh JW, Dvorchik I.

Liver Transpl. 2003 Jul;9(7):693-6.

7.

Optimal timing of the delayed phase in dynamic contrast-enhanced imaging of the liver.

McEvoy SH, Lavelle LP, Malone DE.

Radiology. 2013 Nov;269(2):619. doi: 10.1148/radiol.13131051. No abstract available.

PMID:
24155286
8.

Is resectable hepatocellular carcinoma a contraindication to liver transplantation? A novel decision model based on "number of patients needed to transplant" as measure of transplant benefit.

Vitale A, Cucchetti A, Qiao GL, Cescon M, Li J, Ramirez Morales R, Frigo AC, Xia Y, Tuci F, Shen F, Cillo U, Pinna AD.

J Hepatol. 2014 Jun;60(6):1165-71. doi: 10.1016/j.jhep.2014.01.022. Epub 2014 Feb 6.

PMID:
24508550
9.

Transplant benefit for patients with hepatocellular carcinoma.

Vitale A, Volk M, Cillo U.

World J Gastroenterol. 2013 Dec 28;19(48):9183-8. doi: 10.3748/wjg.v19.i48.9183. Review.

10.

Current challenges in liver transplantation for hepatocellular carcinoma.

Bhoori S, Mazzaferro V.

Best Pract Res Clin Gastroenterol. 2014 Oct;28(5):867-79. doi: 10.1016/j.bpg.2014.08.001. Epub 2014 Aug 22. Review. Erratum in: Best Pract Res Clin Gastroenterol. 2014 Dec;28(6):1115-6.

PMID:
25260314
11.

Toward a better liver graft allocation that accounts for candidates with and without hepatocellular carcinoma.

Toso C, Mazzaferro V, Bruix J, Freeman R, Mentha G, Majno P.

Am J Transplant. 2014 Oct;14(10):2221-7. doi: 10.1111/ajt.12923. Epub 2014 Sep 12. Review.

12.

Who should get a liver graft?

Clavien PA.

J Hepatol. 2009 Apr;50(4):662-3. doi: 10.1016/j.jhep.2009.01.012. Epub 2009 Feb 12. No abstract available.

13.

Liver transplant and hepatocellular carcinoma.

Wong R.

Clin Adv Hematol Oncol. 2016 Dec;14(12):987-989. No abstract available.

PMID:
28212361
14.

Minimal Transplant Survival Benefit for Hepatocellular Carcinoma: Is it Real or an Overestimation of Waitlist Life Expectancy?

Mehta N, Heimbach J, Hirose R, Roberts JP, Yao FY.

Gastroenterology. 2016 Feb;150(2):533-4. doi: 10.1053/j.gastro.2015.08.059. Epub 2015 Dec 21. No abstract available.

PMID:
26718172
15.

Estimation of Liver Transplant Related Survival Benefit: the Devil Is in The Details.

Vitale A, Volk ML, Senzolo M, Frigo AC, Cillo U.

Gastroenterology. 2016 Feb;150(2):534-5. doi: 10.1053/j.gastro.2015.12.002. Epub 2015 Dec 21. No abstract available.

PMID:
26718173
16.

Who should get a liver graft?

Freeman RB, Jamieson N, Schaubel DE, Porte RJ, Villamil FG.

J Hepatol. 2009 Apr;50(4):664-73. doi: 10.1016/j.jhep.2009.01.013. Epub 2009 Feb 12. No abstract available.

17.

Monitoring for post-transplant hepatocellular carcinoma recurrence.

Ortiz J, Danniel J, Chavez M, Davogustto G.

HPB (Oxford). 2012 May;14(5):351; author reply 352. doi: 10.1111/j.1477-2574.2012.00449.x. Epub 2012 Mar 11. No abstract available.

18.

Impact of a living donor liver transplant program for hepatocellular carcinoma to the running local deceased donor liver transplant program.

Sotiropoulos GC, Malagó M, Molmenti EP, Radtke A, Fouzas I, Beckebaum S, Saner FH, Paul A, Lang H, Broelsch CE.

Dig Dis Sci. 2010 Mar;55(3):872-3. doi: 10.1007/s10620-009-0783-7. Epub 2009 Mar 18. No abstract available.

PMID:
19294504
19.

Primary hepatocellular carcinoma: transplant versus resection.

Schwartz ME.

Semin Liver Dis. 1994 May;14(2):135-9. Review. No abstract available.

PMID:
8047897
20.

Liver allocation for HCC: a moving target.

Freeman RB.

Liver Transpl. 2004 Jan;10(1):49-51. No abstract available.

Supplemental Content

Support Center